Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01925690 · ClinicalTrials.gov registry record · NA
Development of a Motivational Intervention to Improve Treatment Adherence in MS
A NA study of Relapsing Remitting Multiple Sclerosis, sponsored by University of Missouri, Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT01925690 is a NA study of Relapsing Remitting Multiple Sclerosis that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 80 participants, below the 199-participant average among 25 other Relapsing Remitting Multiple Sclerosis trials with a reported enrollment target (60% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01925690, a NA study of Relapsing Remitting Multiple Sclerosis, has completed, sponsored by University of Missouri, Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
As many as 50% of MS patients prematurely discontinue their disease modifying medications. For this study, we will develop a telephone-based talk therapy intervention and then conduct a randomized controlled trial. Patients will be assigned to either 5 weekly 20 minute telephone sessions of psychotherapy or a brief education control condition. We hypothesize that patients undergoing phone therapy will be more likely to indicate they are interested in resuming taking disease modifying medications than patients given brief education and treatment as usual.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing-Cognitive Behavioral Therapy
- BEHAVIORAL Brief Education
Study Locations (2)
Missouri
- University of Missouri-Kansas City - Kansas City
New Jersey
- Kessler Rehabillitation Institute - West Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01925690
The ClinicalTrials.gov registry entry for NCT01925690 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 199-participant average among 25 other Relapsing Remitting Multiple Sclerosis trials with a reported enrollment target (60% lower). The listed sponsor is University of Missouri, Kansas City, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Relapsing Remitting Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing-Cognitive Behavioral Therapy is the first listed.
NCT01925690 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Missouri, New Jersey.
Frequently Asked Questions
What is clinical trial NCT01925690 about?
NCT01925690 is a clinical study titled "Development of a Motivational Intervention to Improve Treatment Adherence in MS". As many as 50% of MS patients prematurely discontinue their disease modifying medications. For this study, we will develop a telephone-based talk therapy intervention and then conduct a randomized controlled trial. Patients will be assigned to either 5 weekly 20 minute telephone sessions of psychoth...
What is the current status of trial NCT01925690?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2013-02. Estimated completion is 2015-09.
What conditions does trial NCT01925690 study?
This clinical trial studies the following conditions: Relapsing Remitting Multiple Sclerosis.
What interventions are being tested in trial NCT01925690?
The interventions under investigation include: Motivational Interviewing-Cognitive Behavioral Therapy (BEHAVIORAL), Brief Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01925690?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01925690 being conducted?
This trial has 2 study locations across Missouri, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Relapsing Remitting Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
RECRUITING · NA
-
Functional Outcomes From Diets in Multiple Sclerosis
RECRUITING · NA
-
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
ACTIVE NOT RECRUITING · NA
-
Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)
COMPLETED · NA
-
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
RECRUITING
-
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.